Holland & Knight’s Michael Werner talks to Dr. Russell Medford, President and CEO of Salutria Pharmaceuticals, a privately-held biotech company based in Alpharetta Georgia. Dr. Medford is also co-chair of BIO’s Board Standing Committee on Bioethics. Dr. Medford will be providing testimony on Wednesday November 16 to the Presidential Commission for the Study of Bioethical Issues on Principles Regarding Ethical Performance of International Clinical Trials.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagshealth BIO CEO & Investor Conference BIOTECH agriculture biotechnology Sustainability Patent Reform Greenhouse Gas Emission BIO EVENT climate change BIO Investor Forum global food crisis Benefits of biotech crops Plant biotechnology GMO Answers biotech industry International Food GMOs healthcare
- Most Popular